HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul Matthias Diderichsen Selected Research

Paul Matthias Diderichsen Research Topics

Disease

3Neoplasms (Cancer)
01/2023 - 01/2022
2Chronic Obstructive Pulmonary Disease (COPD)
11/2013 - 06/2013
1Squamous Cell Carcinoma of Head and Neck
09/2023
1Hematologic Neoplasms (Hematological Malignancy)
01/2023
1Body Weight (Weight, Body)
01/2022
1Idiopathic Pulmonary Fibrosis
01/2019
1Crohn Disease (Crohn's Disease)
08/2015
1Rheumatoid Arthritis
08/2015
1Asthma (Bronchial Asthma)
06/2013

Drug/Important Bio-Agent (IBA)

2simurosertibIBA
01/2022 - 01/2022
2Phosphotransferases (Kinase)IBA
01/2022 - 01/2022
2N- ((4'- hydroxybiphenyl- 3- yl)methyl)- 2- (3- (2- ((- 2- hydroxy- 2- (4- hydroxy- 3- ((methylsulfonyl)amino)phenyl)ethyl)amino)- 2- methylpropyl)phenyl)acetamideIBA
11/2013 - 06/2013
1Inhibitor of Apoptosis ProteinsIBA
09/2023
1Cisplatin (Platino)FDA LinkGeneric
09/2023
1fms-Like Tyrosine Kinase 3IBA
01/2023
1Syk KinaseIBA
01/2023
1CreatinineIBA
01/2022
1GLPG1690IBA
01/2019
1lysophosphatidic acidIBA
01/2019
1Rifampin (Rifampicin)FDA LinkGeneric
01/2019
1Janus Kinase 1IBA
08/2015
1GLPG0634IBA
08/2015
1Adrenergic Receptors (Adrenergic Receptor)IBA
11/2013

Therapy/Procedure

1Radiotherapy
09/2023
1Chemoradiotherapy
09/2023
1Oral Administration
01/2022